Core Scientific, Inc. Common Stock
Here’s whether Core Scientific, Inc. Common Stock (CORZ) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 48 — healthy momentum range; strong 1-year return of +45.9%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-4.67% over 10 days); 3-month momentum negative (-16.6%). Currently 33.8% off its 52-week high. Score: +1/7.
CORZ is holding above its long-term 200-day MA ($19.81) but has slipped below the 50-day MA ($23.85), pointing to short-term weakness in an otherwise intact trend. An RSI of 48.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +45.9% compares to +20.4% for SPY (beat the market by 25.5%). The current 33.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.